CGCP Insider Trading Activity and SEC Form 4 Filings
CGCP insider trading summary
No open-market insider purchases or sales of Cardiogenesis Corp (CGCP) have been reported on SEC Form 4 in the past 12 months.
Latest CGCP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 17, 2011 | CL Falcon, Inc. | 10% Owner | Buy | $10.7M (23,401,043 @ $0.46) |
| May 17, 2011 | Cryolife Inc | 10% Owner | Buy | $10.7M (23,401,043 @ $0.46) |
| Apr 17, 2006 | Gary Allen | Director | Buy | $2K (4,500 @ $0.47) |
| Dec 29, 2005 | Gary Allen | Director | Buy | $3K (10,000 @ $0.34) |
| May 19, 2005 | Christine Ocampo | V.P., Chief Financial Officer | Buy | $4K (10,000 @ $0.43) |
| May 19, 2005 | Christine Ocampo | V.P., Chief Financial Officer | Buy | $4K (10,000 @ $0.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.